Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Many individuals experience transient gastrointestinal symptoms during the initial weeks of treatment or following dose escalation, with symptoms often improving as the body adapts to the medication
The drug is currently being evaluated in Phase III clinical development
Presented for research literature review only Lee TK et al
101,102 ME2 depletion, accompanied by an increased NADP + /NADPH ratio and ROS levels, impacts PI3K/AKT signaling and enhances the sensitivity of erythroleukemia and NSCLC cells to cisplatin
If you feel hypothyroid despite normal TSH, your dose likely needs adjustment
US$ 22.66
US$ 28.27
US$ 26.28
US$ 20.42
US$ 23.85
US$ 27.65
US$ 27.23
US$ 23.19
US$ 22.60
US$ 24.91
